ArticleJournal of virology2012

A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.

Flavia Chiuppesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.